Press Releases

Press Releases
Date Title and Summary View
May 8, 2017 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported today that Notices of Allowance has been issued for patents covering key technological features of the Company's Quell® Wearable Pain Relief Technology™ by the European Patent Office, the Japan Patent Office, and the S...
May 5, 2017 Early adopters come together to dialog with the makers of the Quell wearable technology. WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) held its first Quell® Wearable Pain Relief Technology™ user event last Thursday, April 27. As a cust...
Apr 20, 2017 Revenue of $4.3M is up 89% year-over-year Quell device shipments of 18.7K and electrode reorders of 25.4K represent new quarterly highs Quell retail availability expands to nearly 3,000 stores WALTHAM, Mass.--(BUSINESS WIRE)-- ...
Apr 18, 2017 Waltham-based company expands availability into brick-and-mortar locations of leading domestic and home merchandise retailer WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) today announced the availability of its flagship product, Quell®, at select number of ...
Apr 13, 2017 Inaugural initiative of AARP and MedCity News showcases companies and people delivering cutting-edge healthcare solutions for the 50+ market MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it was selected as one of the healthcare...
Apr 12, 2017 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2017 first quarter financial results before the opening of the market on Thursday, April 20, 2017. The Company will host a conference call at 8:00 a.m., Eastern Time on April 20, 2017 to discuss its ...
Mar 15, 2017 Waltham-based company to exhibit its wearable device for widespread pain relief ORLANDO, Fla.--(BUSINESS WIRE)-- Coming together with thousands of leading clinicians who treat patients with chronic pain, NeuroMetrix, Inc. (Nasdaq: NURO) will exhibit Quell®, its FDA-cle...
Mar 1, 2017 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported increased media attention in 2017 on the company's Quell® Wearable Pain Relief Technology™. An Inside Look at the Latest Health Tech - The Dr. Oz Show 3 Amazing New G...
Feb 21, 2017 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell® will be available in over 450 Best Buy® stores nationwide beginning in mid-February and is now available for purchase on BestBuy.com. "More and more consumers are proactively looking for techno...
Jan 26, 2017 2016 revenue $12.0M up 65% year-on-year; Q4 revenue $3.7M up 36% Quell device shipments of 14.3K and electrode reorders of 20K represent new quarterly highs WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW), today reported financial a...
FirstPrevious
2
... NextLast
Add to Briefcase = add release to Briefcase